Comment: Tivanisiran (SYL1001) is a small interfering RNA (siRNA) that is designed to target transient receptor potential cation channel subfamily V member 1 (TRPV1) mRNA to reduce channel abundance and therefore block TRPV1-mediated pain signals [1,3].